Glenmark Pharmaceuticals informs about media release

19 Aug 2024 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1636.05 -2.90 (-0.18%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.